Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)-Reference-Cited by-同舟云学术

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)

Published:2024-07 Issue:10448 Volume:404 Page:145-155
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Adler Amanda I,Coleman Ruth L,Leal Jose,Whiteley William N,Clarke Philip,Holman Rury R

Funder

University of Oxford

Publisher

Elsevier BV

Reference28 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

2. New weight standards for men and women;Stat Bull,1959

3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

4. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Eng J Med,2008

5. Is glycemic control improving in US adults?;Hoerger;Diabetes Care,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management;Diabetologia;2024-08-19

2. It is time to get all the job done: For patients’ sake;European Journal of Internal Medicine;2024-08

3. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin;Diabetes, Obesity and Metabolism;2024-07-11

4. Voting Patterns, Mortality, and Health Inequalities in England;2024-06-26

5. Knowledge and Practice of Foot Care among Patients with Diabetes Attending Diabetes Center, Saudi Arabia;Healthcare;2024-06-22